BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35663313)

  • 21. Thyroid Bethesda Atypia of Undetermined Significance or Follicular Lesion of Undetermined Significance (AUS/FLUS): A Heterogenous Group.
    Maity P; Jha AK; Sengupta M; Basu K; Chatterjee U; Ghosh S
    J Cytol; 2019; 36(4):200-204. PubMed ID: 31741578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of repeat fine-needle aspiration in thyroid nodules categorized as atypia of undetermined significance or follicular lesion of undetermined significance: A single center experience.
    Marin F; Murillo R; Diego C; Jodar E; Acevedo A
    Diagn Cytopathol; 2021 Mar; 49(3):412-417. PubMed ID: 33252841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypia of undetermined significance and follicular lesions of undetermined significance: sonographic assessment for prediction of the final diagnosis.
    Kamaya A; Lewis GH; Liu Y; Akatsu H; Kong C; Desser TS
    J Ultrasound Med; 2015 May; 34(5):767-74. PubMed ID: 25911708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classification of thyroid fine-needle aspiration cytology into Bethesda categories: An institutional experience and review of the literature.
    Alshaikh S; Harb Z; Aljufairi E; Almahari SA
    Cytojournal; 2018; 15():4. PubMed ID: 29531571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.
    Sullivan PS; Hirschowitz SL; Fung PC; Apple SK
    Cancer Cytopathol; 2014 Dec; 122(12):866-72. PubMed ID: 25078420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of malignancy in thyroid nodules with atipia of undetermined significance.
    López Vázquez Y; Penín Álvarez M; San Miguel Fraile P; Barragáns Pérez M
    Endocrinol Nutr; 2015 Dec; 62(10):507-10. PubMed ID: 26526719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.
    Bellevicine C; Sgariglia R; Migliatico I; Vigliar E; D'Anna M; Nacchio MA; Serra N; Malapelle U; Bongiovanni M; Troncone G
    Cancer Cytopathol; 2018 May; 126(5):317-325. PubMed ID: 29469940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid cytology in Pakistan: An institutional audit of the atypia of undetermined significance/follicular lesion of undetermined significance category.
    Fatima S; Qureshi R; Imran S; Idrees R; Ahmad Z; Kayani N; Ahmed A
    Cytopathology; 2021 Mar; 32(2):205-210. PubMed ID: 33098589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytologic subclassification of atypia of undetermined significance may predict thyroid nodules more likely to be malignant at surgery.
    Shrestha RT; Hennessey JV
    Diagn Cytopathol; 2016 Jun; 44(6):492-8. PubMed ID: 27028482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the Reclassification of "Noninvasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma" to "Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features" on the Bethesda System for Reporting Thyroid Cytopathology: A Large Academic Institution's Experience.
    Lau RP; Paulsen JD; Brandler TC; Liu CZ; Simsir A; Zhou F
    Am J Clin Pathol; 2017 Dec; 149(1):50-54. PubMed ID: 29272354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of malignancy in Thyroid "Atypia of undetermined significance/Follicular lesion of undetermined significance" and its subcategories - A 5-year experience.
    Thakur A; Sarin H; Kaur D; Sarin D
    Indian J Pathol Microbiol; 2019; 62(4):544-548. PubMed ID: 31611437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ThyroSeq v3 for Bethesda III and IV: An institutional experience.
    Desai D; Lepe M; Baloch ZW; Mandel SJ
    Cancer Cytopathol; 2021 Feb; 129(2):164-170. PubMed ID: 33030808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Proposal for Separation of Nuclear Atypia and Architectural Atypia in Bethesda Category III (AUS/FLUS) Based on Differing Rates of Thyroid Malignancy.
    Johnson DN; Cavallo AB; Uraizee I; Tanager K; Lastra RR; Antic T; Cipriani NA
    Am J Clin Pathol; 2019 Jan; 151(1):86-94. PubMed ID: 30212867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretransplant Thyroid Findings in Patients With End-Stage Renal Disease.
    Yılmaz Akçay E; Tepeoğlu M; Özdemir BH; Özgün G; Kazancı S; Haberal M
    Exp Clin Transplant; 2016 Nov; 14(Suppl 3):67-70. PubMed ID: 27805516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eliminating the "Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance" category from the Bethesda System for Reporting Thyroid Cytopathology.
    Singh RS; Wang HH
    Am J Clin Pathol; 2011 Dec; 136(6):896-902. PubMed ID: 22095375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignancy rate in thyroid nodules categorized as atypia of undetermined significance or follicular lesion of undetermined significance - An institutional experience.
    Chandra S; Chandra H; Bisht SS
    J Cytol; 2017; 34(3):144-148. PubMed ID: 28701827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytological Diagnoses Associated with Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features According to the Bethesda System for Reporting Thyroid Cytopathology: A Systematic Review and Meta-Analysis.
    Bongiovanni M; Giovanella L; Romanelli F; Trimboli P
    Thyroid; 2019 Feb; 29(2):222-228. PubMed ID: 30426887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytological Sub-Classification of Atypia of Undetermined Significance May Predict Malignancy Risk in Thyroid Nodules.
    Elomami A; Elhag SA; Alseddeeqi E
    Acta Cytol; 2021; 65(3):205-212. PubMed ID: 33524971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.
    Lee JH; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY
    Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes.
    Wong LQ; Baloch ZW
    Adv Anat Pathol; 2012 Sep; 19(5):313-9. PubMed ID: 22885380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.